• NAV
    20.36
  • TODAY'S CHANGE (%)
    Trending Down-0.23 (-1.12%)
  • Investment Style
    Large Cap Growth
  • 52 Week Range
    Low 17.18
    High 21.78
  • Distribution Yield
    0.00%
  • MER
    1.99
  • AUM
    1.7B
  • RRSP Eligibility
    Yes
  • Load Type
    No Load
  • Overall Morningstar Rating
    Please Note: Not Ratedout of 316 funds

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select growth of 10k Options
Graph. See accessible table below
Growth of 10K Chart Accessibility Table. Data as Of Sep 30, 2021
DatePercent Change
September 20210.98%
August 20211.07%
July 20210.97%
June 20210.93%
May 20210.78%
April 20210.83%
March 20210.78%
February 20210.83%
January 20210.87%
December 20200.82%
November 20200.78%
October 20200.66%
September 20200.69%
August 20200.63%
July 20200.64%
June 20200.61%
May 20200.63%
April 20200.53%
March 20200.36%
February 20200.40%
January 20200.44%
December 20190.46%
November 20190.45%
October 20190.32%
September 20190.25%
August 20190.31%
July 20190.34%
June 20190.34%
May 20190.28%
April 20190.29%
March 20190.35%
February 20190.32%
January 20190.29%
December 20180.20%
November 20180.31%
October 20180.25%
September 20180.35%
August 20180.35%
July 20180.27%
June 20180.24%
May 20180.20%
April 20180.14%
March 20180.15%
February 20180.16%
January 20180.17%
December 20170.11%
November 20170.14%
October 20170.11%
September 20170.08%
August 20170.07%
July 20170.05%
June 20170.07%
May 20170.06%
April 20170.08%
March 20170.03%
February 20170.04%
January 2017-0.05%
December 2016-0.06%
November 2016-0.05%
October 2016-0.09%
September 2016-0.04%
August 2016-0.05%
July 2016-0.02%
June 2016-0.08%
May 2016-0.05%
April 2016-0.12%
March 2016-0.11%
February 2016-0.09%
January 2016-0.05%
December 20150.09%
November 20150.03%
October 20150.00%
No reports available

Calendar Year Total Returns

Total Returns Table
YearFundBest-Fit IndexCategory
As of 2021-09-30
2020
+25.13%
+20.52%
---
2019
+21.49%
-1.17%
---
2018
+8.41%
+16.34%
---
2017
+18.34%
+5.07%
---
2016
-14.45%
+18.09%
---
Asset Class
No data available
Sectors
Sectors
Healthcare93.8%
Basic Mat.0.7%
Financial Serv.s0.5%
Consumer Defensive0.0%
Communication Services0
Consumer Cyclical0
Energy0
Industrials0
Real Estate0
Technology0
Utilities0
Geographic Region
Geographic Region
United States
89.5%
Europe
3.7%
Asia/Oceania
0.3%
Canada
0.1%
Africa
0
Latin America
0
As of 2021-06-30
Top 10 Holdings
Company Name sortablePosition sortableAllocation sortable
Allocation
1 Month Change
sortable
Market Value sortable
United StatesUNH
UnitedHealth Group Inc
Long
6.1%
+0.25%
$120.9M
United StatesTMO
Thermo Fisher Scientific Inc
Long
3.7%
+0.95%
$73.5M
United StatesISRG
Intuitive Surgical Inc
Long
3.6%
+0.38%
$71.7M
United StatesLLY
Eli Lilly and Co
Long
3.5%
+2.81%
$69.6M
United StatesDHR
Danaher Corp
Long
3.4%
+0.39%
$67.9M
United StatesSYK
Stryker Corp
Long
2.3%
+0.50%
$46.1M
United StatesVRTX
Vertex Pharmaceuticals Inc
Long
2.2%
+0.70%
$44.1M
United StatesCI
Cigna Corp
Long
1.9%
+0.17%
$37.2M
United StatesBNTX
BioNTech SE ADR
Long
1.8%
+0.88%
$36.6M
United StatesCNC
Centene Corp
Long
1.8%
+0.17%
$35.9M
As of 2021-10-28
Fund Profile
Best Fit Index
Lipper Health/Biotech Fund Avg
Category
Sponsor
T. Rowe Price Associates, Inc.
Inception
October 20, 2015
As of 2021-06-30

The fundamental investment objective of the Fund is to achieve long-term capital appreciation by investing primarily in equity securities of companies located in the United States and other countries, that are engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. Health sciences companies are defined as those companies that commit or derive at least 50% of their assets, revenues, or operating profits from the activities just described.

Holding Details
Total Net Assets$323.6M
Annual Portfolio Turnover34.58%
Equity Style
Large Cap Growth
Credit Quality / Duration
---
Tax-Adjusted Rating
Please Note: Not Rated
FUND IS OPEN TO NEW INVESTORS
Initial Investment(s)$100
Subsequent Investment(s)$100
Initial RRSP Investment(s)$100
Subsequent RRSP Investment(s)$100
Fees & Expenses
Maximum Initial Sales Fees---
Maximum Deferred Sales Fees---
Actual Management Fee1.50%
Actual Mgmt. Expense Ratio (MER)1.99%
Load TypeNo Load

Morningstar Ratings

Morningstar Ratings Table
Time HorizonStar Rating
Tax-Adjusted Rating
OverallPlease Note: Not Rated---No Tax-Adjusted Rating Available
3 YearPlease Note: Not Rated---No Tax-Adjusted Rating Available
5 YearPlease Note: Not Rated---No Tax-Adjusted Rating Available
10 YearPlease Note: Not Rated---No Tax-Adjusted Rating Available
As of 2021-09-30

Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.

Style Box is calculated only using the long position holdings of the portfolio.

Management & Contact

Contact Information

T. Rowe Price Associates, Inc.
P.O. Box 100 66 Wellington Street West TD Bank Tower
Toronto ON Canada M5K 1G8
Tel: 800-588-8054
Fax: 866-782-3167
Portfolio Manager since July 01, 2016
Ziad Bakri